Skip to content

Bard® InLay® Ureteral Stent with HydroGlide™ Guidewire 777728Recalls & reported problems

C. R. Bard, Inc. · INLAY URETERAL STENT W/HYDROGLIDE GUIDEWIRE · Class 2 · Implant

All models of Bard InLay Ureteral Stent with HydroGlide Guidewire (17)

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
2
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 10801741014632), received between May 25, 2023 and Jun 9, 2023 — classified as 2 malfunctions.

The most frequently reported specific device problem is “Material Fragmentation” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Most reported problems

Device problems

  • Material Fragmentation1
  • Tear, Rip or Hole in Device Packaging1

Patient problems

  • No Clinical Signs, Symptoms or Conditions2

Recent adverse event reports

The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.

  • MalfunctionJun 9, 2023Material Fragmentation; Material Fragmentation

    IT WAS REPORTED THAT THE SUTURE FROM THE URETERAL STENT PACKAGE WAS RUPTURED.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 17098963 ↗
  • MalfunctionMay 25, 2023Tear, Rip or Hole in Device Packaging; Tear, Rip or Hole in Device Packaging

    IT WAS REPORTED THAT THE INNER PACKAGE WAS BROKEN.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 17001905 ↗

Other STENT, URETERAL devices

All STENT, URETERAL devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page